<Emphasis Type="Italic">Aconitum</Emphasis> biotechnology: recent trends and emerging perspectives

The genus Aconitum (consists more than 250 species) is one of the most important clades of highly valued medicinal plants. Aconitum species are very essential in the traditional device of medication and feature excessive business demand in the herbal marketplace. Some of biologically energetic compounds, e.g., aconitine, indaconitine, pseudoacontine, and so on, had been recognized, and new formulations primarily based on those compounds are being produced as rapid rate. This has led to extensive and rather unregulated exploitation of the species in the wild making the genus a threatened group. Conventional breeding and propagation methods have contributed significantly, but these could not meet up with the ever increasing demands of herbal drug industry globally. Biotechnological interventions, therefore, emerge as an alternative approach in terms of higher production and conservation as well. In recent years, several reports have been published on in vitro propagation of various important Aconitum species. However, advanced biotechnological approaches, such as synthetic seed production and hairy root cultures, are still lacking with only a few reports available. The current review presents an updated overview and critical assessment of secondary data concerning the past and recent biotechnological approaches and interventions in genus Aconitum. This review also attempts to provide a detailed account of work explored so far in micropropagation and emphasizes over the areas not attempted yet, which will act as a baseline data as well as valuable information for different stakeholders and researchers working on various aspects of Aconitum biotechnology.     

Genetic differentiation among various populations of the diamondback moth, Plutella xylostella (Lepidoptera: Yponomeutidae)

Genetic variation among 14 populations of Plutella xylostella (Linnaeus) from USA (Geneva, New York), Brazil (Brasilia), Japan (Okayama), The Philippines (Caragan de Oyo), Uzbekistan (Tashkent), France (Montpellier), Benin (Cotonou), South Africa (Johannesburg), Réunion Island (Montvert), and five localities in Australia (Adelaide, Brisbane, Mareeba, Melbourne, Sydney) were assessed by analysis of allozyme frequencies at seven polymorphic loci. Most of the populations were not in Hardy-Weinberg equilibrium and had a deficit in heterozygotes. The global differentiation among populations was estimated by the fixation index (Fst) at 0.103 for the 14 populations and at 0.047 when populations from Australia and Japan, which differed most and had a strong genetic structure, were excluded from the analysis. By contrast, the populations from Benin (West Africa) and Brazil (South America) were very similar to each other. Genetic differentiation among the populations was not correlated with geographical distance.     

Respirophasic Variations in the QRS Complex and Echocardiographic Equivalent in Pulmonary Embolism

A respirophasic variation of the QRS complex was observed in a patient with bilateral pulmonary embolism and pulmonary hypertension. An analogous variation of the Sa systolic velocity of the tricuspid annular tissue Doppler imaging was also noticed. Both phaenomena persisted until the clinical and haemodynamic improvement of the patient. A mechanistic approach of the electric phaenomenon is proposed.     

Kinesins in the Arabidopsis genome: A comparative analysis among eukaryotes

Background  

Receptor protein tyrosine phosphatase rho (RPTPρ, gene symbol PTPRT) is a member of the type IIB RPTP family. These transmembrane molecules have been linked to signal transduction, cell adhesion and neurite extension. The extracellular segment contains MAM, Ig-like and fibronectin type III domains, and the intracellular segment contains two phosphatase domains. The human RPTPρ gene is located on chromosome 20q12-13.1, and the mouse gene is located on a syntenic region of chromosome 2. RPTPρ expression is restricted to the central nervous system.